1. Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle
- Author
-
Teun van der Bom, A. H. Zwinderman, Barbara J.M. Mulder, Hubert W. Vliegen, Gertjan T. Sieswerda, Michiel M. Winter, Arie P. J. van Dijk, Jolien W. Roos-Hesslink, Petronella G. Pieper, Berto J. Bouma, Maarten Groenink, Cardiovascular Centre (CVC), Amsterdam Cardiovascular Sciences, Cardiology, General Internal Medicine, Radiology and Nuclear Medicine, Amsterdam Public Health, and Epidemiology and Data Science
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Ventricular Dysfunction, Right ,Tetrazoles ,Angiotensin II Receptor Blockers ,congenital-heart-disease minimally symptomatic patients great-arteries corrected transposition dobutamine stress mustard procedure follow-up failure adults mortality ,Double-Blind Method ,Internal medicine ,MINIMALLY SYMPTOMATIC PATIENTS ,medicine ,Clinical endpoint ,Humans ,DOBUTAMINE STRESS ,FAILURE ,Heart Atria ,Prospective Studies ,Mustard procedure ,CONGENITAL-HEART-DISEASE ,medicine.diagnostic_test ,Cardiovascular diseases [NCEBP 14] ,business.industry ,GREAT-ARTERIES ,MORTALITY ,Magnetic resonance imaging ,Stroke Volume ,Valine ,ADULTS ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,Treatment Outcome ,CORRECTED TRANSPOSITION ,Valsartan ,Great arteries ,Ventricle ,Circulatory system ,Cardiology ,Ventricular Function, Right ,Female ,Cardiology and Cardiovascular Medicine ,business ,Tomography, X-Ray Computed ,FOLLOW-UP ,Angiotensin II Type 1 Receptor Blockers ,MUSTARD PROCEDURE ,medicine.drug ,Follow-Up Studies - Abstract
Contains fulltext : 89513.pdf (Publisher’s version ) (Closed access) BACKGROUND: Angiotensin II receptor blockers have been proven to be beneficial in left ventricular failure. In patients with a morphologic right ventricle supporting the systemic circulation, its efficacy has not yet been established. METHODS: We designed a multicenter, prospective, randomized, double-blind, placebo-controlled trial studying the effect of valsartan in patients with a systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries. The primary end point is the change in right ventricular ejection fraction as measured by cardiovascular magnetic resonance or multidetector row cardiac computed tomography in case of pacemaker patients. CONCLUSION: This large prospective, double-blind, randomized, placebo-controlled trial will establish the role of angiotensin II receptor blockers (valsartan) in the treatment of patients with a systemic right ventricle. 01 november 2010
- Published
- 2010